Rebound Pruritus and Urticaria Post-discontinuation of Chronic Cetirizine Use: A Case Report. [PDF]
Seng JJB, Cai M, Oka P.
europepmc +1 more source
Rebound Pruritus and Urticaria After Discontinuation of Chronic Antihistamine Use—A Scoping Review
Rebound pruritus and urticaria have been reported after discontinuation of chronic cetirizine or levocetirizine use only. Symptoms typically occur within 0.5–5 days after stopping therapy and appear more frequently reported in female patients. Re‐initiation of antihistamines is the most commonly effective management strategy, highlighting the need for ...
Jun Jie Benjamin Seng +2 more
wiley +1 more source
Standardized pressure provocation as an objective clinical marker of omalizumab response in delayed pressure urticaria: an open-label, real-life, prospective cohort. [PDF]
Konstantinou GN, Podder I.
europepmc +1 more source
Investigation of the Pathomechanism of Chronic Cough Using an In Vitro Approach
Clinical &Experimental Allergy, Volume 55, Issue 3, Page 247-249, March 2025.
Umesh Singh, Jonathan A. Bernstein
wiley +1 more source
Contact Sensitization in Adults With Atopic Dermatitis: A 21‐Year Single‐Center Tertiary Experience
A graphical abstract has been included as supplemental material. ABSTRACT Background Atopic dermatitis is a common chronic inflammatory skin condition. Data on contact sensitization in adults with atopic dermatitis remain limited. Objectives To investigate the prevalence of contact sensitization in adults with and without AD: Patients/Methods A ...
Francesca Caroppo +5 more
wiley +1 more source
Successful treatment of chronic spontaneous urticaria and bladder pain syndrome with montelukast and/or omalizumab: a case report. [PDF]
Bulut G.
europepmc +1 more source
Cosmetic Adverse Reactions and Prognostic Factors: A Retrospective Cohort Study in Wuhan, China
This study reveals that being under 20 or having a history of allergies significantly increases the risk of long‐term symptoms after a cosmetic adverse reaction. These findings help dermatologists identify high‐risk patients for proactive management and tailored preventive strategies.
Ayan Hasen +4 more
wiley +1 more source
Does IL-31 level have more significance in chronic urticaria, when compared with IL-33 level? [PDF]
Özden G +5 more
europepmc +1 more source
The overall prevalence of sensitization to FA/FRs was 1.9% (48/2592). ACD was diagnosed in 37.5% (18/48), comprising non‐occupational ACD (83.3%) and occupational ACD (16.7%). FA 1%–2% aq. failed to detect FR sensitisation in 31.9% (n = 15/47) and FR‐induced ACD in 35.3% (n = 6/17) of patients.
Esen Özkaya +2 more
wiley +1 more source

